Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Institute of Bioengineering, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Nat Rev Mol Cell Biol. 2024 Aug;25(8):639-653. doi: 10.1038/s41580-024-00718-y. Epub 2024 Apr 2.
The field of protein design has made remarkable progress over the past decade. Historically, the low reliability of purely structure-based design methods limited their application, but recent strategies that combine structure-based and sequence-based calculations, as well as machine learning tools, have dramatically improved protein engineering and design. In this Review, we discuss how these methods have enabled the design of increasingly complex structures and therapeutically relevant activities. Additionally, protein optimization methods have improved the stability and activity of complex eukaryotic proteins. Thanks to their increased reliability, computational design methods have been applied to improve therapeutics and enzymes for green chemistry and have generated vaccine antigens, antivirals and drug-delivery nano-vehicles. Moreover, the high success of design methods reflects an increased understanding of basic rules that govern the relationships among protein sequence, structure and function. However, de novo design is still limited mostly to α-helix bundles, restricting its potential to generate sophisticated enzymes and diverse protein and small-molecule binders. Designing complex protein structures is a challenging but necessary next step if we are to realize our objective of generating new-to-nature activities.
在过去的十年中,蛋白质设计领域取得了显著的进展。在历史上,纯粹基于结构的设计方法的可靠性较低,限制了其应用,但最近结合基于结构和基于序列的计算以及机器学习工具的策略,极大地改进了蛋白质工程和设计。在这篇综述中,我们讨论了这些方法如何能够设计出越来越复杂的结构和具有治疗相关性的活性。此外,蛋白质优化方法提高了复杂真核蛋白的稳定性和活性。由于其可靠性的提高,计算设计方法已被应用于改善治疗药物和用于绿色化学的酶,并产生了疫苗抗原、抗病毒药物和药物输送纳米载体。此外,设计方法的高成功率反映了人们对控制蛋白质序列、结构和功能之间关系的基本规则的理解有所增加。然而,从头设计仍然主要局限于α-螺旋束,限制了其产生复杂酶以及各种蛋白质和小分子结合物的潜力。设计复杂的蛋白质结构是一个具有挑战性但必要的下一步,如果我们要实现产生新天然活性的目标的话。